Longitudinal studies involving weekly measurement of urinary oestrogen and pregnanediol excretion were performed in 55 post-partum women to identify the patterns of returning fertility. The women kept diaries of breast-feeding episodes, mucus symptoms and times of bleeding; some recorded basal body temperature and acts of intercourse. The study represented a total time of 36 years (7-8 months per woman). The majority of the women were breast-feeding throughout the study. During lactation amenorrhoea, there was complete ovarian quiescence in twothirds of the subjects and minimal cyclic activity in the others. The first bleeds were associated with anovulatory ovarian activity in 40% of the women, with normal ovulation in 19%, with ovulation but short luteal phases in 25% and with ovulation but deficient luteal phases in 16%. The incidence of normal ovulatory cycles increased with time after delivery and with the number of cycles after delivery and eventually reached 85% even though many women were still breast-feeding at the time. Twenty-two pregnancies occurred, fourteen being unplanned: eight women were fully breast-feeding at the time of conception. Mucus symptoms correlated with the hormone values in approximately 60% of cycles. However, some women had symptoms which were difficult to interpret during their early cycles or potential fertility was not indicated by raised mucus scores or the presence of the peak mucus symptom. These problems together with the resulting confusion appeared to be the major causes for the unplanned pregnancies. Methods for coping with these problems are discussed.
Urinary oestrogen and pregnanediol values were measured in 24 boys and 38 girls between the ages of 2 and 13 years. Longitudinal studies were conducted on eight girls, two of whom collected for periods of 4 and 5 years which included menarche and in one case establishment of ovulation. Highly sensitive assay methods were developed for measuring the very small amounts of oestrone, oestradiol and oestriol and pregnanediol present in the urine of young children. The total oestrogen values were within the submicrogram range of 0-1-0-5 //g/24 hr in the children aged 2 -8 years, with no differences seen between the boys and girls. After the age of 8 years, oestrogen values above 1 //g/24 hr began to be encountered and by age 1\\ years the majority of subjects were recording oestrogen values above this figure. The rise in the oestrogen values was more rapid in the girls than in the boys. Evidence was presented that a value of approximately 1 //g/24 hr represents the minimum oestrogen production for the initiation of breast development. The oestrogen values were fluctuating with irregular periodicities at all ages and the gradual general rises seen after the age of 8 years could be arrested at any stage for a year or more. Menarche was preceded by marked periodic fluctuations in oestrogen output which peaked above 15 //g/24 hr. In all subjects studied, the initial bleeding cycles were anovulatory as judged by the low pregnanediol values, the usual pattern being one of fluctuating oestrogen production. One subject was studied fully through to the establishment of ovulation, which first occurred 12 months after menarche. The approach of ovulation was indicated by pre-menstrual rises in pregnanediol which increased in amplitude from 0-4 mg/24 hr until finally 2 mg/24 hr was exceeded (the value accepted for ovulation). Evidence was presented that the interval from menarche to ovulation in different individuals was very variable, extending from ovulation at menarche itself to periods of more than a year. Recording of self-observed symptoms of production of cervical mucus could be of considerable value in documenting these events in larger populations. 43 44 J-B. Brown, P. Harrisson andM. A. Smith
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.